sglt2 inhibitors and glp-1 receptor agonists inhibitors: a couple at last? SGLT2 Inhibitors and GLP-1 Receptor

Another small trial found CoQ10 may slow progression of hearing loss associated with a mitochondrial genetic mutation (Angeli 2005)

While TGA-approved peptide-based medicines such as semaglutide and tirzepatide have undergone extensive trials and have strongly backed evidence, Dr Kelly said there is limited scientific evidence behind the claims being made for other peptide products promoted and sold online

doi: 10.18632/oncotarget.6568 43 WeissWAAldapeKMohapatraGFeuersteinBGBishopJM

The aims of the study were (1) To examine the present use of vitamin B12 in our practice and (2) To achieve a more appropriate and efficient use of it

Not advised to be used during pregnancy or breastfeeding

Lactoferrin: Structure, function, denaturation and digestion